ErrataErratum
Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu and Chengping Hu
Cancer Biology & Medicine May 2020, 17 (2) 513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0029
Xingsheng Hu
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Dongyong Yang
2Department of Pulmonary Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362100, China
Yalun Li
3Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
Li Li
4Department of Respiratory Medicine, Daping Hospital, Chongqing 400042, China
Yan Wang
5Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
Peng Chen
6Department of Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Song Xu
7Department of Thoracic Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China
Xingxiang Pu
8Department of Medical Oncology, Hunan Cancer Hospital, Changsha 410006, China
Wei Zhu
9Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China
Pengbo Deng
10Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China
Junyi Ye
11Burning Rock Biotech, Guangzhou 510300, China
Hanhan Zhang
11Burning Rock Biotech, Guangzhou 510300, China
Analyn Lizaso
11Burning Rock Biotech, Guangzhou 510300, China
Hao Liu
11Burning Rock Biotech, Guangzhou 510300, China
Xinru Mao
11Burning Rock Biotech, Guangzhou 510300, China
Hai Huang
11Burning Rock Biotech, Guangzhou 510300, China
Qian Chu
12Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Chengping Hu
10Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China
References
- 1.↵
- Hu X,
- Yang D,
- Li Y,
- Li L,
- Wang Y,
- Chen P, et al.
In this issue
Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu
Cancer Biology & Medicine May 2020, 17 (2) 513; DOI: 10.20892/j.issn.2095-3941.2020.0029
Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu
Cancer Biology & Medicine May 2020, 17 (2) 513; DOI: 10.20892/j.issn.2095-3941.2020.0029
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.